REMDESIVIR and DEATH

Overview

DEATH is the #5 most commonly reported adverse reaction for REMDESIVIR, manufactured by Gilead Sciences, Inc.. There are 751 FDA adverse event reports linking REMDESIVIR to DEATH. This represents approximately 3.7% of all 20,319 adverse event reports for this drug.

Patients taking REMDESIVIR who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DEATH is moderately reported among REMDESIVIR users, representing a notable but not dominant share of adverse events.

Other Side Effects of REMDESIVIR

In addition to death, the following adverse reactions have been reported for REMDESIVIR:

• OFF LABEL USE — 2,208 reports
• ALANINE AMINOTRANSFERASE INCREASED — 933 reports
• COVID 19 — 896 reports
• DRUG INEFFECTIVE — 762 reports
• BRADYCARDIA — 651 reports
• ASPARTATE AMINOTRANSFERASE INCREASED — 627 reports
• ACUTE KIDNEY INJURY — 622 reports
• RESPIRATORY FAILURE — 526 reports
• COVID 19 PNEUMONIA — 480 reports
• LIVER FUNCTION TEST INCREASED — 420 reports

Other Drugs Associated with DEATH

The following drugs have also been linked to death in FDA adverse event reports:

Does REMDESIVIR cause DEATH?

DEATH has been reported as an adverse event in 751 FDA reports for REMDESIVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DEATH with REMDESIVIR?

DEATH accounts for approximately 3.7% of all adverse event reports for REMDESIVIR, making it a notable side effect.

What should I do if I experience DEATH while taking REMDESIVIR?

If you experience death while taking REMDESIVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages